Menu

House Bill Could Help Employers Dodge GINA

HR 1313 could circumvent protections offered by the Genetic Information Nondiscrimination Act, enabling employers to incentivize employee sharing of genetic and other medical information.

Mar 13, 2017
Joshua A. Krisch

i124NEWS.TVThe Genetic Information Nondiscrimination Act (GINA) prohibits US employers and health insurance companies from making decisions based on the results of genetic screenings, with several exceptions. If employees voluntarily submit their genetic information as part of a workplace wellness program, for instance, they are not protected by GINA. But employers must not coerce workers into doing so.

Now, House Republicans have approved HR 1313, a bill that, if enacted, would remove at least one of GINA’s protections: essentially, it would allow employers to pressure workers into submitting their genetic information to the company in exchange for up to 30 percent reductions in health insurance costs. Once employees have submitted their information (voluntarily, as part of a workplace wellness program), few of GINA’s protections would apply.

“What this bill would do is completely take away the protections of existing laws,” Jennifer Mathis of the Bazelon Center for Mental Health Law told STAT News. GINA and similar legislation “would be pretty much eviscerated,” she added.

See: "Protecting Patients from Genetic Discrimination"

The American Academy of Pediatrics and nearly 70 other organizations have drafted a letter opposing the bill, which has been passed along to the House Ways and Means Committee and has yet to be considered by the Senate. “We strongly oppose any legislation that would allow employers to inquire about employees’ private genetic information or medical information unrelated to their ability to do their jobs, and to impose draconian penalties on employees who choose to keep that information private,” the organizations wrote.

Supporters of the bill argue that GINA and other federal nondiscrimination laws impose so many regulations on workplace wellness programs that it is difficult for employers to implement them. Wellness programs can decrease the costs of health care through gym discounts and other incentives for employees who maintain healthy lifestyles. HR 1313 “is trying to streamline the regulatory scheme,” Kathryn Wilber of the American Benefits Council told The New York Times.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.